Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

SNPS vs PLAB

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
SNPS
Synopsys, Inc.

Software - Infrastructure

TechnologyNASDAQ • US
Market Cap$96.55B
5Y Perf.+178.8%
PLAB
Photronics, Inc.

Semiconductors

TechnologyNASDAQ • US
Market Cap$3.00B
5Y Perf.+334.4%

SNPS vs PLAB — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
SNPS logoSNPS
PLAB logoPLAB
IndustrySoftware - InfrastructureSemiconductors
Market Cap$96.55B$3.00B
Revenue (TTM)$8.01B$862M
Net Income (TTM)$1.10B$136M
Gross Margin75.1%35.1%
Operating Margin10.8%24.5%
Forward P/E34.9x23.1x
Total Debt$14.29B$24K
Cash & Equiv.$2.89B$492M

SNPS vs PLABLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

SNPS
PLAB
StockMay 20May 26Return
Synopsys, Inc. (SNPS)100278.8+178.8%
Photronics, Inc. (PLAB)100434.4+334.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: SNPS vs PLAB

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: PLAB leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Synopsys, Inc. is the stronger pick specifically for growth and revenue expansion and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
SNPS
Synopsys, Inc.
The Income Pick

SNPS is the clearest fit if your priority is income & stability and growth exposure.

  • beta 1.79
  • Rev growth 15.1%, EPS growth -44.6%, 3Y rev CAGR 15.2%
  • 9.5% 10Y total return vs PLAB's 410.2%
Best for: income & stability and growth exposure
PLAB
Photronics, Inc.
The Value Pick

PLAB carries the broadest edge in this set and is the clearest fit for valuation efficiency.

  • PEG 0.67 vs SNPS's 2.59
  • Lower P/E (23.1x vs 34.9x), PEG 0.67 vs 2.59
  • 15.8% margin vs SNPS's 13.8%
Best for: valuation efficiency
See the full category breakdown
CategoryWinnerWhy
GrowthSNPS logoSNPS15.1% revenue growth vs PLAB's -2.0%
ValuePLAB logoPLABLower P/E (23.1x vs 34.9x), PEG 0.67 vs 2.59
Quality / MarginsPLAB logoPLAB15.8% margin vs SNPS's 13.8%
Stability / SafetySNPS logoSNPSBeta 1.79 vs PLAB's 2.88
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)PLAB logoPLAB+177.2% vs SNPS's +6.5%
Efficiency (ROA)PLAB logoPLAB7.2% ROA vs SNPS's 2.3%, ROIC 15.5% vs 3.0%

SNPS vs PLAB — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

SNPSSynopsys, Inc.
FY 2025
License and Maintenance
49.5%$3.5B
License
28.5%$2.0B
Technology Service
22.0%$1.6B
PLABPhotronics, Inc.
FY 2024
Mainstream Integrated Circuits
47.3%$410M
High-end Integrated Circuits
26.4%$228M
High-end Flat Panel Displays
22.5%$195M
Mainstream Flat Panel Displays
3.9%$33M

SNPS vs PLAB — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLPLABLAGGINGSNPS

Income & Cash Flow (Last 12 Months)

Evenly matched — SNPS and PLAB each lead in 3 of 6 comparable metrics.

SNPS is the larger business by revenue, generating $8.0B annually — 9.3x PLAB's $862M. Profitability is closely matched — net margins range from 15.8% (PLAB) to 13.8% (SNPS). On growth, SNPS holds the edge at +65.5% YoY revenue growth, suggesting stronger near-term business momentum.

MetricSNPS logoSNPSSynopsys, Inc.PLAB logoPLABPhotronics, Inc.
RevenueTrailing 12 months$8.0B$862M
EBITDAEarnings before interest/tax$1.7B$287M
Net IncomeAfter-tax profit$1.1B$136M
Free Cash FlowCash after capex$2.3B$66M
Gross MarginGross profit ÷ Revenue+75.1%+35.1%
Operating MarginEBIT ÷ Revenue+10.8%+24.5%
Net MarginNet income ÷ Revenue+13.8%+15.8%
FCF MarginFCF ÷ Revenue+28.5%+7.6%
Rev. Growth (YoY)Latest quarter vs prior year+65.5%+6.1%
EPS Growth (YoY)Latest quarter vs prior year-78.8%+8.8%
Evenly matched — SNPS and PLAB each lead in 3 of 6 comparable metrics.

Valuation Metrics

PLAB leads this category, winning 7 of 7 comparable metrics.

At 22.8x trailing earnings, PLAB trades at a 64% valuation discount to SNPS's 62.7x P/E. Adjusting for growth (PEG ratio), PLAB offers better value at 0.66x vs SNPS's 4.65x — a lower PEG means you pay less per unit of expected earnings growth.

MetricSNPS logoSNPSSynopsys, Inc.PLAB logoPLABPhotronics, Inc.
Market CapShares × price$96.6B$3.0B
Enterprise ValueMkt cap + debt − cash$108.0B$2.5B
Trailing P/EPrice ÷ TTM EPS62.73x22.85x
Forward P/EPrice ÷ next-FY EPS est.34.89x23.08x
PEG RatioP/E ÷ EPS growth rate4.65x0.66x
EV / EBITDAEnterprise value multiple68.53x8.78x
Price / SalesMarket cap ÷ Revenue13.69x3.53x
Price / BookPrice ÷ Book value/share2.88x1.95x
Price / FCFMarket cap ÷ FCF71.57x50.32x
PLAB leads this category, winning 7 of 7 comparable metrics.

Profitability & Efficiency

PLAB leads this category, winning 9 of 9 comparable metrics.

PLAB delivers a 8.3% return on equity — every $100 of shareholder capital generates $8 in annual profit, vs $4 for SNPS. PLAB carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to SNPS's 0.50x. On the Piotroski fundamental quality scale (0–9), PLAB scores 6/9 vs SNPS's 3/9, reflecting solid financial health.

MetricSNPS logoSNPSSynopsys, Inc.PLAB logoPLABPhotronics, Inc.
ROE (TTM)Return on equity+3.6%+8.3%
ROA (TTM)Return on assets+2.3%+7.2%
ROICReturn on invested capital+3.0%+15.5%
ROCEReturn on capital employed+3.3%+13.1%
Piotroski ScoreFundamental quality 0–936
Debt / EquityFinancial leverage0.50x0.00x
Net DebtTotal debt minus cash$11.4B-$492M
Cash & Equiv.Liquid assets$2.9B$492M
Total DebtShort + long-term debt$14.3B$24,000
Interest CoverageEBIT ÷ Interest expense6.38x3777.78x
PLAB leads this category, winning 9 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

PLAB leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in PLAB five years ago would be worth $40,919 today (with dividends reinvested), compared to $21,238 for SNPS. Over the past 12 months, PLAB leads with a +177.2% total return vs SNPS's +6.5%. The 3-year compound annual growth rate (CAGR) favors PLAB at 52.0% vs SNPS's 10.7% — a key indicator of consistent wealth creation.

MetricSNPS logoSNPSSynopsys, Inc.PLAB logoPLABPhotronics, Inc.
YTD ReturnYear-to-date+5.0%+55.9%
1-Year ReturnPast 12 months+6.5%+177.2%
3-Year ReturnCumulative with dividends+35.7%+251.0%
5-Year ReturnCumulative with dividends+112.4%+309.2%
10-Year ReturnCumulative with dividends+953.8%+410.2%
CAGR (3Y)Annualised 3-year return+10.7%+52.0%
PLAB leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — SNPS and PLAB each lead in 1 of 2 comparable metrics.

SNPS is the less volatile stock with a 1.79 beta — it tends to amplify market swings less than PLAB's 2.88 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PLAB currently trades 98.3% from its 52-week high vs SNPS's 77.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSNPS logoSNPSSynopsys, Inc.PLAB logoPLABPhotronics, Inc.
Beta (5Y)Sensitivity to S&P 5001.79x2.88x
52-Week HighHighest price in past year$651.73$53.00
52-Week LowLowest price in past year$376.18$16.59
% of 52W HighCurrent price vs 52-week peak+77.4%+98.3%
RSI (14)Momentum oscillator 0–10067.965.1
Avg Volume (50D)Average daily shares traded1.9M921K
Evenly matched — SNPS and PLAB each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates SNPS as "Buy" and PLAB as "Buy". Consensus price targets imply 7.8% upside for SNPS (target: $544) vs -5.3% for PLAB (target: $49).

MetricSNPS logoSNPSSynopsys, Inc.PLAB logoPLABPhotronics, Inc.
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$543.57$49.33
# AnalystsCovering analysts2711
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises0
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%+3.2%
Insufficient data to determine a leader in this category.
Key Takeaway

PLAB leads in 3 of 6 categories — strongest in Valuation Metrics and Profitability & Efficiency. 2 categories are tied.

Best OverallPhotronics, Inc. (PLAB)Leads 3 of 6 categories
Loading custom metrics...

SNPS vs PLAB: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is SNPS or PLAB a better buy right now?

For growth investors, Synopsys, Inc.

(SNPS) is the stronger pick with 15. 1% revenue growth year-over-year, versus -2. 0% for Photronics, Inc. (PLAB). Photronics, Inc. (PLAB) offers the better valuation at 22. 8x trailing P/E (23. 1x forward), making it the more compelling value choice. Analysts rate Synopsys, Inc. (SNPS) a "Buy" — based on 27 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — SNPS or PLAB?

On trailing P/E, Photronics, Inc.

(PLAB) is the cheapest at 22. 8x versus Synopsys, Inc. at 62. 7x. On forward P/E, Photronics, Inc. is actually cheaper at 23. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Photronics, Inc. wins at 0. 67x versus Synopsys, Inc. 's 2. 59x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — SNPS or PLAB?

Over the past 5 years, Photronics, Inc.

(PLAB) delivered a total return of +309. 2%, compared to +112. 4% for Synopsys, Inc. (SNPS). Over 10 years, the gap is even starker: SNPS returned +953. 8% versus PLAB's +410. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — SNPS or PLAB?

By beta (market sensitivity over 5 years), Synopsys, Inc.

(SNPS) is the lower-risk stock at 1. 79β versus Photronics, Inc. 's 2. 88β — meaning PLAB is approximately 61% more volatile than SNPS relative to the S&P 500. On balance sheet safety, Photronics, Inc. (PLAB) carries a lower debt/equity ratio of 0% versus 50% for Synopsys, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — SNPS or PLAB?

By revenue growth (latest reported year), Synopsys, Inc.

(SNPS) is pulling ahead at 15. 1% versus -2. 0% for Photronics, Inc. (PLAB). On earnings-per-share growth, the picture is similar: Photronics, Inc. grew EPS 9. 1% year-over-year, compared to -44. 6% for Synopsys, Inc.. Over a 3-year CAGR, SNPS leads at 15. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — SNPS or PLAB?

Synopsys, Inc.

(SNPS) is the more profitable company, earning 18. 9% net margin versus 16. 1% for Photronics, Inc. — meaning it keeps 18. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PLAB leads at 24. 5% versus 13. 0% for SNPS. At the gross margin level — before operating expenses — SNPS leads at 77. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is SNPS or PLAB more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Photronics, Inc. (PLAB) is the more undervalued stock at a PEG of 0. 67x versus Synopsys, Inc. 's 2. 59x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Photronics, Inc. (PLAB) trades at 23. 1x forward P/E versus 34. 9x for Synopsys, Inc. — 11. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SNPS: 7. 8% to $543. 57.

08

Which pays a better dividend — SNPS or PLAB?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is SNPS or PLAB better for a retirement portfolio?

For long-horizon retirement investors, Synopsys, Inc.

(SNPS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+953. 8% 10Y return). Photronics, Inc. (PLAB) carries a higher beta of 2. 88 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SNPS: +953. 8%, PLAB: +410. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between SNPS and PLAB?

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: SNPS is a mid-cap high-growth stock; PLAB is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

SNPS

High-Growth Compounder

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 32%
  • Net Margin > 8%
Run This Screen
Stocks Like

PLAB

Steady Growth Compounder

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 9%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform SNPS and PLAB on the metrics below

Revenue Growth>
%
(SNPS: 65.5% · PLAB: 6.1%)
Net Margin>
%
(SNPS: 13.8% · PLAB: 15.8%)
P/E Ratio<
x
(SNPS: 62.7x · PLAB: 22.8x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.